Nucleoside analogues and nucleobases in cancer treatment
Top Cited Papers
- 1 July 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (7) , 415-424
- https://doi.org/10.1016/s1470-2045(02)00788-x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupBritish Journal of Haematology, 2001
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998
- Combination therapy with gemcitabine in non-small cell lung cancerEuropean Journal Of Cancer, 1997
- FLAG (Fludarabine, Cytarabine, G‐CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effectsEuropean Journal of Haematology, 1996
- FludarabineDrugs, 1993
- Biochemical Modulation of Arabinosylcytosine for Therapy of LeukemiasLeukemia & Lymphoma, 1993
- Cladribine (2-chlorodeoxyadenosine)The Lancet, 1992
- Metabolism and action of purine nucleoside analogsPharmacology & Therapeutics, 1991
- Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cellsChemico-Biological Interactions, 1982
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJournal of Clinical Investigation, 1982